A detailed history of Opes Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Opes Wealth Management LLC holds 316 shares of LLY stock, worth $277,545. This represents 0.05% of its overall portfolio holdings.

Number of Shares
316
Previous 236 33.9%
Holding current value
$277,545
Previous $209,000 16.27%
% of portfolio
0.05%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$727.2 - $932.06 $58,176 - $74,564
80 Added 33.9%
316 $243,000
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $772 - $960
1 Added 0.43%
236 $209,000
Q2 2024

Aug 05, 2024

BUY
$724.87 - $909.04 $170,344 - $213,624
235 New
235 $212,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $835B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Opes Wealth Management LLC Portfolio

Follow Opes Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opes Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opes Wealth Management LLC with notifications on news.